AstraZeneca nasal spray vaccine for Covid fizzles in small, early trial
AstraZeneca Plc’s nasal spray vaccine failed to elicit a strong immune response to Covid-19 in an early trial, a blow to the UK drug giant’s ambitions for developing an alternative approach to preventing the disease.
The spray vaccine…
Read More...
Read More...